Reuters logo
BRIEF-Aldeyra Therapeutics reports Q3 loss per share of $0.32
2017年11月9日 / 下午12点42分 / 10 天前

BRIEF-Aldeyra Therapeutics reports Q3 loss per share of $0.32

Nov 9 (Reuters) - Aldeyra Therapeutics Inc

* Aldeyra Therapeutics announces third quarter 2017 financial results

* Q3 loss per share $0.32

* Q3 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S

* ‍Cash, cash equivalents, and marketable securities were $47.9 million as of September 30, 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below